Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak
Background COVID‐19 was temporally associated with an increase in out‐of‐hospital cardiac arrests, but the underlying mechanisms are unclear. We sought to determine if patients with implantable defibrillators residing in areas with high COVID‐19 activity experienced an increase in defibrillator shoc...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-06-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.120.019708 |
| _version_ | 1827746630761185280 |
|---|---|
| author | Selçuk Adabag Patrick Zimmerman Adam Black Mohammad Madjid Payam Safavi‐Naeini Alan Cheng |
| author_facet | Selçuk Adabag Patrick Zimmerman Adam Black Mohammad Madjid Payam Safavi‐Naeini Alan Cheng |
| author_sort | Selçuk Adabag |
| collection | DOAJ |
| description | Background COVID‐19 was temporally associated with an increase in out‐of‐hospital cardiac arrests, but the underlying mechanisms are unclear. We sought to determine if patients with implantable defibrillators residing in areas with high COVID‐19 activity experienced an increase in defibrillator shocks during the COVID‐19 outbreak. Methods and Results Using the Medtronic (Mounds View, MN) Carelink database from 2019 and 2020, we retrospectively determined the incidence of implantable defibrillator shock episodes among patients residing in New York City, New Orleans, LA, and Boston, MA. A total of 14 665 patients with a Medtronic implantable defibrillator (age, 66±13 years; and 72% men) were included in the analysis. Comparing analysis time periods coinciding with the COVID‐19 outbreak in 2020 with the same periods in 2019, we observed a larger mean rate of defibrillator shock episodes per 1000 patients in New York City (17.8 versus 11.7, respectively), New Orleans (26.4 versus 13.5, respectively), and Boston (30.9 versus 20.6, respectively) during the COVID‐19 surge. Age‐ and sex‐adjusted hurdle model showed that the Poisson distribution rate of defibrillator shocks for patients with ≥1 shock was 3.11 times larger (95% CI, 1.08–8.99; P=0.036) in New York City, 3.74 times larger (95% CI, 0.88–15.89; P=0.074) in New Orleans, and 1.97 times larger (95% CI, 0.69–5.61; P=0.202) in Boston in 2020 versus 2019. However, the binomial odds of any given patient having a shock episode was not different in 2020 versus 2019. Conclusions Defibrillator shock episodes increased during the higher COVID‐19 activity in New York City, New Orleans, and Boston. These observations may provide insights into COVID‐19–related increase in cardiac arrests. |
| first_indexed | 2024-03-11T05:29:01Z |
| format | Article |
| id | doaj.art-aebeff85726c447192a5df0ac2118c39 |
| institution | Directory Open Access Journal |
| issn | 2047-9980 |
| language | English |
| last_indexed | 2024-03-11T05:29:01Z |
| publishDate | 2021-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| spelling | doaj.art-aebeff85726c447192a5df0ac2118c392023-11-17T17:19:41ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802021-06-01101110.1161/JAHA.120.019708Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 OutbreakSelçuk Adabag0Patrick Zimmerman1Adam Black2Mohammad Madjid3Payam Safavi‐Naeini4Alan Cheng5Division of Cardiology Minneapolis Veterans Affairs Health Care System Minneapolis MNCardiac Rhythm Heart FailureMedtronic, Inc Minneapolis MNCardiac Rhythm Heart FailureMedtronic, Inc Minneapolis MNDepartment of Medicine McGovern Medical SchoolUTHealth Houston TXElectrophysiology Clinical Research and Innovations Texas Heart Institute Houston TXCardiac Rhythm Heart FailureMedtronic, Inc Minneapolis MNBackground COVID‐19 was temporally associated with an increase in out‐of‐hospital cardiac arrests, but the underlying mechanisms are unclear. We sought to determine if patients with implantable defibrillators residing in areas with high COVID‐19 activity experienced an increase in defibrillator shocks during the COVID‐19 outbreak. Methods and Results Using the Medtronic (Mounds View, MN) Carelink database from 2019 and 2020, we retrospectively determined the incidence of implantable defibrillator shock episodes among patients residing in New York City, New Orleans, LA, and Boston, MA. A total of 14 665 patients with a Medtronic implantable defibrillator (age, 66±13 years; and 72% men) were included in the analysis. Comparing analysis time periods coinciding with the COVID‐19 outbreak in 2020 with the same periods in 2019, we observed a larger mean rate of defibrillator shock episodes per 1000 patients in New York City (17.8 versus 11.7, respectively), New Orleans (26.4 versus 13.5, respectively), and Boston (30.9 versus 20.6, respectively) during the COVID‐19 surge. Age‐ and sex‐adjusted hurdle model showed that the Poisson distribution rate of defibrillator shocks for patients with ≥1 shock was 3.11 times larger (95% CI, 1.08–8.99; P=0.036) in New York City, 3.74 times larger (95% CI, 0.88–15.89; P=0.074) in New Orleans, and 1.97 times larger (95% CI, 0.69–5.61; P=0.202) in Boston in 2020 versus 2019. However, the binomial odds of any given patient having a shock episode was not different in 2020 versus 2019. Conclusions Defibrillator shock episodes increased during the higher COVID‐19 activity in New York City, New Orleans, and Boston. These observations may provide insights into COVID‐19–related increase in cardiac arrests.https://www.ahajournals.org/doi/10.1161/JAHA.120.019708cardiac arrestCOVID‐19epidemiologyimplantable cardioverter‐defibrillatorpandemic |
| spellingShingle | Selçuk Adabag Patrick Zimmerman Adam Black Mohammad Madjid Payam Safavi‐Naeini Alan Cheng Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease cardiac arrest COVID‐19 epidemiology implantable cardioverter‐defibrillator pandemic |
| title | Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak |
| title_full | Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak |
| title_fullStr | Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak |
| title_full_unstemmed | Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak |
| title_short | Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak |
| title_sort | implantable cardioverter defibrillator shocks during covid 19 outbreak |
| topic | cardiac arrest COVID‐19 epidemiology implantable cardioverter‐defibrillator pandemic |
| url | https://www.ahajournals.org/doi/10.1161/JAHA.120.019708 |
| work_keys_str_mv | AT selcukadabag implantablecardioverterdefibrillatorshocksduringcovid19outbreak AT patrickzimmerman implantablecardioverterdefibrillatorshocksduringcovid19outbreak AT adamblack implantablecardioverterdefibrillatorshocksduringcovid19outbreak AT mohammadmadjid implantablecardioverterdefibrillatorshocksduringcovid19outbreak AT payamsafavinaeini implantablecardioverterdefibrillatorshocksduringcovid19outbreak AT alancheng implantablecardioverterdefibrillatorshocksduringcovid19outbreak |